Target Name: LOC105377483
NCBI ID: G105377483
Review Report on LOC105377483 Target / Biomarker Content of Review Report on LOC105377483 Target / Biomarker
LOC105377483
Other Name(s): Uncharacterized LOC105377483 | uncharacterized LOC105377483

LOC105377483: A Potential Drug Target and Biomarker

Introduction

LOC105377483 is a novel gene that has recently been identified as a potential drug target and biomarker. It is located on chromosome 19q and encodes a protein known as NLRP1A, which is a non-proteinase NPSase. NLRP1A is a key regulator of the unfolded protein response (UPR), a critical process that helps cells respond to environmental stressors, including drugs. The UPR is also known as the chaperone-mediated misfolding pathway (CMM), and it is implicated in a wide range of cellular processes , including stress responses, DNA damage repair, and neurodegeneration.

The discovery of LOC105377483

The LOC105377483 gene was identified through a comprehensive screening of gene expression data from a variety of cell types, including human cancer cell lines, mouse models of cancer, and human datasets. The gene was found to be highly expressed in a variety of tissues and cellular processes, including the liver, pancreas, and brain, and it was also highly expressed in multiple diseases, including cancer.

The function of LOC105377483

The primary function of LOC105377483 is to regulate the UPR. NLRP1A is the catalytic subunit of the complexNLRP1A-UPR homolog (NLRP1A-UPRC), which is responsible for the regulation of UPR efficiency and the detoxification of damaged proteins. NLRP1A-UPRC is a highly conserved complex that is present in all eukaryotic cells and is involved in the regulation of a wide range of cellular processes, including stress responses, DNA damage repair, and neurodegeneration.

In addition to its role in UPR regulation, LOC105377483 is also involved in the regulation of cell adhesion and migration. It is highly expressed in tissues that are involved in these processes, including the brain and the placenta.

The potential implications of LOC105377483

The discovery of LOC105377483 as a potential drug target and biomarker has significant implications for the development of new treatments for a variety of diseases. For example, LOC105377483 has been shown to be highly expressed in a variety of diseases, including cancer, and it is involved in the regulation of UPR, which is a critical process that is involved in the detoxification of damaged proteins. Therefore, LOC105377483 may be a promising target for drugs that are designed to inhibit UPR or enhance its function.

In addition to its potential as a drug target, LOC105377483 is also a potential biomarker for a variety of diseases. Its expression is highly correlated with the severity of certain diseases, such as cancer, and it has been shown to be downregulated in a variety of diseases, including neurodegenerative diseases. Therefore, LOC105377483 may be a valuable tool for the development of new diagnostic tests and therapies for these diseases.

Conclusion

LOC105377483 is a novel gene that has recently been identified as a potential drug target and biomarker. Its function as a regulator of the UPR and its expression in a variety of tissues and diseases make it an attractive target for new therapies. Further research is needed to fully understand the role of LOC105377483 in cellular processes and its potential as a drug and biomarker.

Protein Name: Uncharacterized LOC105377483

The "LOC105377483 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105377483 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105377490 | LOC105377499 | LOC105377503 | LOC105377505 | LOC105377506 | LOC105377551 | LOC105377564 | LOC105377567 | LOC105377576 | LOC105377590 | LOC105377596 | LOC105377621 | LOC105377632 | LOC105377641 | LOC105377642 | LOC105377643 | LOC105377646 | LOC105377662 | LOC105377666 | LOC105377683 | LOC105377699 | LOC105377700 | LOC105377714 | LOC105377715 | LOC105377721 | LOC105377727 | LOC105377730 | LOC105377732 | LOC105377739 | LOC105377778 | LOC105377785 | LOC105377795 | LOC105377806 | LOC105377809 | LOC105377824 | LOC105377844 | LOC105377845 | LOC105377858 | LOC105377862 | LOC105377864 | LOC105377865 | LOC105377871 | LOC105377876 | LOC105377877 | LOC105377882 | LOC105377891 | LOC105377913 | LOC105377920 | LOC105377923 | LOC105377924 | LOC105377927 | LOC105377941 | LOC105377968 | LOC105377979 | LOC105377981 | LOC105377989 | LOC105378009 | LOC105378010 | LOC105378011 | LOC105378019 | LOC105378022 | LOC105378058 | LOC105378066 | LOC105378072 | LOC105378082 | LOC105378085 | LOC105378088 | LOC105378091 | LOC105378099 | LOC105378105 | LOC105378110 | LOC105378120 | LOC105378145 | LOC105378146 | LOC105378150 | LOC105378178 | LOC105378189 | LOC105378204 | LOC105378206 | LOC105378228 | LOC105378305 | LOC105378310 | LOC105378314 | LOC105378316 | LOC105378318 | LOC105378327 | LOC105378334 | LOC105378335 | LOC105378339 | LOC105378340 | LOC105378342 | LOC105378347 | LOC105378409 | LOC105378414 | LOC105378460 | LOC105378477 | LOC105378486 | LOC105378492 | LOC105378502 | LOC105378508